Literature DB >> 10212378

Evaluation of Meditech ABPM-04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol.

I Barna1, A Keszei, A Dunai.   

Abstract

BACKGROUND: The use of ambulatory blood pressure measuring devices has become widespread in the diagnosis of hypertension. The accuracy of the device is fundamental for the diagnosis and treatment of the disease.
OBJECTIVE: Internationally accepted validation of the newest ambulatory blood pressure measuring device, the ABPM-04 prototype, manufactured by Meditech Ltd. PATIENTS AND METHODS: Validation was carried out by assessing 94 outpatients, according to the British Hypertension Society protocol.
RESULTS: The test device achieved grade B on the scale defined in the British Hypertension Society protocol, for both systolic and diastolic blood pressure. The mean and standard deviation of the difference between measurements of the test device and the mercury standard for both systolic and diastolic blood pressure were within the recommendations of the Association for the Advancement of Medical Instrumentation.
CONCLUSION: The present study demonstrates that the Meditech ABPM-04 ambulatory blood pressure measuring device complies with the above mentioned requirements, and thus can be recommended for clinical use.

Entities:  

Mesh:

Year:  1998        PMID: 10212378

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  16 in total

1.  Blood pressure measuring devices: recommendations of the European Society of Hypertension.

Authors:  E O'Brien; B Waeber; G Parati; J Staessen; M G Myers
Journal:  BMJ       Date:  2001-03-03

2.  Non-invasive vascular impedance measures demonstrate ocular vasoconstriction during isometric exercise.

Authors:  Andrew J Morgan; Sarah L Hosking
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

3.  Seasonal variation in meteorological parameters and office, ambulatory and home blood pressure: predicting factors and clinical implications.

Authors:  George S Stergiou; Aikaterini Myrsilidi; Anastasios Kollias; Antonios Destounis; Leonidas Roussias; Petros Kalogeropoulos
Journal:  Hypertens Res       Date:  2015-09-03       Impact factor: 3.872

4.  Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.

Authors:  Dénes Páll; Ildikó Szántó; Zoltán Szabó
Journal:  Clin Drug Investig       Date:  2014-10       Impact factor: 2.859

5.  The effect of low-dose carvedilol, nebivolol, and metoprolol on central arterial pressure and its determinants: a randomized clinical trial.

Authors:  Péter Studinger; Ádám G Tabák; Chen-Huan Chen; Paolo Salvi; Taha E H Othmane; Péter Torzsa; Judit Kapocsi; Bertalan C Fekete; András Tislér
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-04       Impact factor: 3.738

6.  Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial.

Authors:  Colin D Chue; Jonathan N Townend; Richard P Steeds; Charles J Ferro
Journal:  Trials       Date:  2011-02-02       Impact factor: 2.279

7.  Reproducibility of wrist home blood pressure measurement with position sensor and automatic data storage.

Authors:  Sakir Uen; Rolf Fimmers; Miriam Brieger; Georg Nickenig; Thomas Mengden
Journal:  BMC Cardiovasc Disord       Date:  2009-05-27       Impact factor: 2.298

8.  Effects of short-term continuous Montmorency tart cherry juice supplementation in participants with metabolic syndrome.

Authors:  Terun Desai; Michael Roberts; Lindsay Bottoms
Journal:  Eur J Nutr       Date:  2020-08-12       Impact factor: 5.614

9.  Comparing the associations of clinic vs. ambulatory blood pressure with subclinical organ damage in young healthy adults: the African-PREDICT study.

Authors:  Dimoné Botha; Yolandi Breet; Aletta E Schutte
Journal:  Hypertens Res       Date:  2021-02-09       Impact factor: 3.872

10.  ST segment depression in hypertensive patients: a comparison of exercise test versus Holter ECG.

Authors:  Sakir Uen; Rolf Fimmers; Burkhard Weisser; Johannes Baulmann; Osman Balta; Georg Nickenig; Thomas Mengden
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.